Status:
RECRUITING
Interstitial Lung Disease Research Unit Biobank
Lead Sponsor:
University of Kansas Medical Center
Conditions:
Interstitial Lung Disease
Sarcoidosis
Eligibility:
All Genders
18+ years
Brief Summary
Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.
Detailed Description
The University of Kansas ILD and Rare Lung Disease clinic sees hundreds of new patients per year. The investigators would like to leverage this resource to develop an Interstitial Lung Disease Researc...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
- The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
- The participant is ≥ 18 years of age.
- The participant has signed an approved consent for this study (living patients only)
Exclusion
Key Trial Info
Start Date :
August 9 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2032
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05392881
Start Date
August 9 2021
End Date
March 1 2032
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Kansas Medical Center
Kansas City, Kansas, United States, 66160